BioStem Technologies, Inc. (OTC: BSEM) reported Q1 EPS of $0.94, $0.56 better than the analyst estimate of $0.38. Revenue for the quarter came in at $102.87 million versus the consensus estimate of $82.13 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.